Immunomodulatory Effects and Mechanisms of Species and Their Bioactive Compounds: A Review.

Front Pharmacol

Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.

Published: April 2021

species (family: Zingiberaceae) are widely utilized in traditional medicine to treat diverse immune-related disorders. There have been many scientific studies on their immunomodulating effects to support their ethnopharmacological uses. In this review, the efficacy of six species, namely, L., Roxb, Valeton & Zijp, Roxb. (Christm.) Roscoe, and Roxb., and their bioactive metabolites to modulate the immune system, their mechanistic effects, and their potential to be developed into effective and safe immunomodulatory agents are highlighted. Literature search has been carried out extensively to gather significant findings on immunomodulating activities of these plants. The immunomodulatory effects of species were critically analyzed, and future research strategies and appropriate perspectives on the plants as source of new immunomodulators were discussed. Most of the pharmacological investigations to evaluate their immunomodulatory effects were and experiments on the crude extracts of the plants. The extracts were not chemically characterized or standardized. Of all the species investigated, the immunomodulatory effects of were the most studied. Most of the bioactive metabolites responsible for the immunomodulating activities were not determined, and mechanistic studies to understand the underlying mechanisms were scanty. There are limited clinical studies to confirm their efficacy in human. Of all the bioactive metabolites, only curcumin is undergoing extensive clinical trials based on its anti-inflammatory properties and main use as an adjuvant for the treatment of cancer. More in-depth studies to understand the underlying mechanisms using experimental animal models of immune-related disorders and elaborate bioavailability, preclinical pharmacokinetics, and toxicity studies are required before clinical trials can be pursued for development into immunomodulatory agents.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120430PMC
http://dx.doi.org/10.3389/fphar.2021.643119DOI Listing

Publication Analysis

Top Keywords

immunomodulatory effects
16
bioactive metabolites
12
immune-related disorders
8
immunomodulatory agents
8
immunomodulating activities
8
studies understand
8
understand underlying
8
underlying mechanisms
8
clinical trials
8
immunomodulatory
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!